| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Department of Endocrinology and Metabolism and 2 Institute of Pathology, Odense University Hospital, Odense, Denmark; 3 Institute of Cancer Biology, Danish Cancer Society; and 4 Bartholin Instituttet, Kommunehospitalet, Copenhagen, Denmark
Requests for reprints: Jorge S. Burns, Laboratory for Molecular Endocrinology, KMEB, Department of Endocrinology and Metabolism, Odense University Hospital, Medical Biotechnology Center, Winsløwparken 25, DK-5000 Odense C, Denmark. Phone: 45-6550-4081; Fax: 45-6550-3950; E-mail: jburns{at}health.sdu.dk.
Long-term cultures of telomerase-transduced adult human mesenchymal stem cells (hMSC) may evolve spontaneous genetic changes leading to tumorigenicity in immunodeficient mice (e.g., hMSC-TERT20). We wished to clarify whether this unusual phenotype reflected a rare but dominant subpopulation or if the stem cell origin allowed most cells to behave as cancer stem cells. Cultures of the hMSC-TERT20 strain at population doubling 440 were highly clonogenic (94%). From 110 single-cell clones expanded by 20 population doublings, 6 underwent detailed comparison. Like the parental population, each clone had 
1.2 days doubling time with loss of contact inhibition. All retained 1,25-(OH)2 vitamin D3–induced expression of osteoblastic markers: collagen type I, alkaline phosphatase, and osteocalcin. All shared INK4a/ARF gene locus deletion and epigenetic silencing of the DBCCR1 tumor suppressor gene. Despite in vitro commonality, only four of six clones shared the growth kinetics and 100% tumorigenicity of the parental population. In contrast, one clone consistently formed latent tumors and the other established tumors with only 30% penetrance. Changing the in vitro microenvironment to mimic in vivo growth aspects revealed concordant clonal heterogeneity. Latent tumor growth correlated with extracellular matrix entrapment of multicellular spheroids and high procollagen type III expression. Poor tumorigenicity correlated with in vitro serum dependence and high p27Kip1 expression. Aggressive tumorigenicity correlated with good viability plus capillary morphogenesis on serum starvation and high cyclin D1 expression. Thus, hMSC-TERT20 clones represent cancer stem cells with hierarchical tumorigenicity, providing new models to explore the stem cell hypothesis for cancer.
This article has been cited by other articles:
|
|
 |
|
  G. Lazennec and C. Jorgensen Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit? Stem Cells, June 1, 2008; 26(6): 1387 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-Z. Wu Origin of Cancer Stem Cells: The Role of Self-Renewal and Differentiation Ann. Surg. Oncol., February 1, 2008; 15(2): 407 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Aguilar, E. Nye, J. Chan, M. Loebinger, B. Spencer-Dene, N. Fisk, G. Stamp, D. Bonnet, and S. M. Janes Murine but Not Human Mesenchymal Stem Cells Generate Osteosarcoma-Like Lesions in the Lung Stem Cells, June 1, 2007; 25(6): 1586 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-l. Yen, C.-C. Chien, I.-m. Chiu, H.-I Huang, Y.-C. Chen, H.-I Hu, and B. L. Yen Multilineage Differentiation and Characterization of the Human Fetal Osteoblastic 1.19 Cell Line: A Possible In Vitro Model of Human Mesenchymal Progenitors Stem Cells, January 1, 2007; 25(1): 125 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Doering, B. Gangadharan, and H. T. Spencer Marrow-Derived Stromal Cells as Gene Transfer Vehicles in a Murine Model of Hemophilia A. Blood (ASH Annual Meeting Abstracts), November 16, 2006; 108(11): 5489 - 5489. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. F. Zhou, M. Bosch-Marce, H. Okuyama, B. Krishnamachary, H. Kimura, L. Zhang, D. L. Huso, and G. L. Semenza Spontaneous Transformation of Cultured Mouse Bone Marrow-Derived Stromal Cells. Cancer Res., November 15, 2006; 66(22): 10849 - 10854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. POLAK and A. E. BISHOP Stem Cells and Tissue Engineering: Past, Present, and Future Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 352 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y. Klinger, J. L. Blum, B. Hearn, B. Lebow, and L. E. Niklason Tissue Engineering Special Feature: Relevance and safety of telomerase for human tissue engineering PNAS, February 21, 2006; 103(8): 2500 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kassem, J.S. Burns, J. Garcia Castro, and D. Rubio Munoz Adult Stem Cells and Cancer Cancer Res., October 15, 2005; 65(20): 9601 - 9601. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
